Dr. Shaaban is an Assistant Professor of Pathology at the University of Utah School of Medicine, and the medical director of pharmacogenetics and molecular genetics at ARUP Laboratories. She graduated from Mansoura University Medical School in Egypt, then went on to obtain a PhD in Human Genetics at the Graduate School of Medicine Dentistry and Pharmaceutical Science at Okayama University in Japan. After a genetics research fellowship at Harvard Medical School and Boston Children's Hospital, she finished a clinical molecular genetics fellowship at the department of Genetics and Genomics of Icahn School of Medicine at Mount Sinai, NY.
Dr. Shaaban is board certified by the American Board of Medical Genetics and Genomics and is a fellow of the American College of Medical Genetics and Genomics. Her research and academic interests focus on molecular genetic testing for rare inherited diseases and the validation and implementation of pharmacogenetics testing and personalized genomics.
Board Certification and Academic Information
Academic Departments
Pathology
- Primary
Dr. Shaaban is an Assistant Professor of Pathology at the University of Utah School of Medicine, and the medical director of pharmacogenetics and molecular genetics at ARUP Laboratories. She graduated from Mansoura University Medical School in Egypt, then went on to obtain a PhD in Human Genetics at the Graduate School of Medicine Dentistry and Pharmaceutical Science at Okayama University in Japan. After a genetics research fellowship at Harvard Medical School and Boston Children's Hospital, she finished a clinical molecular genetics fellowship at the department of Genetics and Genomics of Icahn School of Medicine at Mount Sinai, NY.
Dr. Shaaban is board certified by the American Board of Medical Genetics and Genomics and is a fellow of the American College of Medical Genetics and Genomics. Her research and academic interests focus on molecular genetic testing for rare inherited diseases and the validation and implementation of pharmacogenetics testing and personalized genomics.